Brand naming and testing pharmaceutical products requires depth of insight into the industry.  

We specialize because it's important that you know: 

 
° What kinds of names are easy to write and to pronounce. 

° Which elements of the names connote "strength" or efficacy.  

° Which names are more easily marketed Direct To Consumer. 

° The possibility/probability that a certain name might be confused with another product-directly affecting patient safety issues. 

° What bearing a certain name will have on the FDA's drug review process. With insight into the procedures of the FDA's Labeling & Nomenclature Committee, we're better equipped to help in the approval process.   

For pharmaceutical naming, each naming group is comprised of both physicians and creative group members.  The MD's give us insight into their specialties.   The creative group members can then transform the data into memorable and effective names. 

Oftentimes, we'll get "knee jerk" reactions from the physicians during the creative process.  A more focused naming group produces better results.    

We then check each name candidate for trademark availability and for similarities to other Rx trade names.   We consider how each name will effect accuracy of prescribing or dispensing the medication.  
    

For the Biotechnology sector, Medibrand can bring added value to your research methods/patents and products by creating an effective identity where there once was none.  
 

Surgical/Hospital suppliers can benefit from Medibrand's knowledge of the industry and how one product may win the market share just by having the right trade name.